About ZYUS Life Sciences
ZYUS Life Sciences is a company based in Saskatoon (Canada) founded in 2018 by Brent Zettl.. ZYUS Life Sciences has raised $19.5 million across 9 funding rounds. ZYUS Life Sciences has completed 1 acquisition, including Revon Systems. ZYUS Life Sciences operates in a competitive market with competitors including Sanity Group, Terraflos, Avicanna, Little Green Pharma and IMCannabis, among others.
- Headquarter Saskatoon, Canada
- Founders Brent Zettl
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zyus Life Sciences Corporation
-
Annual Revenue
$334.3 K (USD)37.04as on Dec 31, 2024
-
Net Profit
$-23.49 M (USD)20.63as on Dec 31, 2024
-
EBITDA
$-8.58 M (USD)22.48as on Dec 31, 2024
-
Total Equity Funding
$19.5 M (USD)
in 9 rounds
-
Latest Funding Round
$1.06 M (USD), Post-IPO
Nov 07, 2025
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ZYUS Life Sciences
ZYUS Life Sciences is a publicly listed company on the TSXV with ticker symbol ZYUS in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of ZYUS Life Sciences
ZYUS Life Sciences has successfully raised a total of $19.5M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.06 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $1.1M
-
First Round
First Round
(20 May 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Post-IPO - ZYUS Life Sciences | Valuation |
investors |
|
| Jul, 2025 | Amount | Post-IPO - ZYUS Life Sciences | Valuation |
investors |
|
| Jun, 2025 | Amount | Post-IPO - ZYUS Life Sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by ZYUS Life Sciences
ZYUS Life Sciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Revon Systems. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Digital therapeutic solutions for chronic care management are offered.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - ZYUS Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zyus Life Sciences Comparisons
Competitors of ZYUS Life Sciences
ZYUS Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sanity Group, Terraflos, Avicanna, Little Green Pharma and IMCannabis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| domain | founded_year | HQ Location |
Medical cannabis products are provided based on GMP processes.
|
|
| domain | founded_year | HQ Location |
Plant-derived cannabinoid products are developed for medical and consumer uses.
|
|
| domain | founded_year | HQ Location |
Manufacturer of medicinal cannabis for therapeutic use
|
|
| domain | founded_year | HQ Location |
Developer of medical cannabis products
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zyus Life Sciences
Frequently Asked Questions about ZYUS Life Sciences
When was ZYUS Life Sciences founded?
ZYUS Life Sciences was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is ZYUS Life Sciences located?
ZYUS Life Sciences is headquartered in Saskatoon, Canada. It is registered at Saskatoon, Saskatchewan, Canada.
Who is the current CEO of ZYUS Life Sciences?
Brent Zettl is the current CEO of ZYUS Life Sciences. They have also founded this company.
Is ZYUS Life Sciences a funded company?
ZYUS Life Sciences is a funded company, having raised a total of $19.5M across 9 funding rounds to date. The company's 1st funding round was a Post-IPO of $182.45K, raised on May 20, 2019.
What is the annual revenue of ZYUS Life Sciences?
Annual revenue of ZYUS Life Sciences is $334.3K as on Dec 31, 2024.
What does ZYUS Life Sciences do?
ZYUS Life Sciences was founded in 2018 in Saskatoon, Canada, within the biotechnology sector. Cannabis-derived therapeutics are developed for various medical indications, with emphasis on cannabinoid-based products and protein-based formulations. Targeted relief is provided to patients through these innovations. The lead candidate, Trichomylin, is designed to address chronic pain. Operations center on research and formulation development in this specialized field.
Who are the top competitors of ZYUS Life Sciences?
ZYUS Life Sciences's top competitors include Avicanna, Neocannbio and IMCannabis.
Is ZYUS Life Sciences publicly traded?
Yes, ZYUS Life Sciences is publicly traded on TSXV under the ticker symbol ZYUS.
How many acquisitions has ZYUS Life Sciences made?
ZYUS Life Sciences has made 1 acquisition, including Revon Systems.
What is ZYUS Life Sciences's ticker symbol?
The ticker symbol of ZYUS Life Sciences is ZYUS on TSXV.